(MENAFN- PR Newswire)
GALWAY, Ireland, Nov. 5, 2024 /PRNewswire/ --
Medtronic plc (NYSE:MDT ), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2025 on Tuesday, November 19, 2024. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at . The news release will include summary financial information for the company's second quarter of fiscal year 2025, which ended on Friday, October 25, 2024.
Medtronic will host a video webcast at 7:00 a.m. CST on November 19, 2024, to discuss results for its second quarter of full fiscal year 2025. The webcast can be accessed at .
Within 24 hours of the broadcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at .
Looking ahead, Medtronic plans to report its third, and fourth quarter fiscal year 2025 results on Tuesday, February 18, 2025 and Wednesday, May 21, 2025, respectively. For these events, confirmation and additional details will be provided closer to the specific event.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission - to alleviate pain, restore health, and extend life - unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people second, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit
and follow Medtronic on LinkedIn .
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
| Contacts: |
|
|
|
| Erika
Winkels
|
Ryan
Weispfenning |
| Public Relations
|
Investor Relations |
| +1-763-526-8478
|
+1-763-505-4626 |
SOURCE Medtronic plc
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
MENAFN05112024003732001241ID1108854120
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.